Cargando…

MicroRNAs Which Can Prognosticate Aggressiveness of Bladder Cancer

Bladder cancer (BC) is still characterized by a very high death rate in patients with this disease. One of the reasons for this is the lack of adequate markers which could help determine the biological potential of the tumor to develop into its invasive stage. It has been found that some microRNAs (...

Descripción completa

Detalles Bibliográficos
Autores principales: Borkowska, Edyta Marta, Konecki, Tomasz, Pietrusiński, Michał, Borowiec, Maciej, Jabłonowski, Zbigniew
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6826751/
https://www.ncbi.nlm.nih.gov/pubmed/31615011
http://dx.doi.org/10.3390/cancers11101551
_version_ 1783465164837748736
author Borkowska, Edyta Marta
Konecki, Tomasz
Pietrusiński, Michał
Borowiec, Maciej
Jabłonowski, Zbigniew
author_facet Borkowska, Edyta Marta
Konecki, Tomasz
Pietrusiński, Michał
Borowiec, Maciej
Jabłonowski, Zbigniew
author_sort Borkowska, Edyta Marta
collection PubMed
description Bladder cancer (BC) is still characterized by a very high death rate in patients with this disease. One of the reasons for this is the lack of adequate markers which could help determine the biological potential of the tumor to develop into its invasive stage. It has been found that some microRNAs (miRNAs) correlate with disease progression. The purpose of this study was to identify which miRNAs can accurately predict the presence of BC and can differentiate low grade (LG) tumors from high grade (HG) tumors. The study included 55 patients with diagnosed bladder cancer and 30 persons belonging to the control group. The expression of seven selected miRNAs was estimated with the real-time PCR technique according to miR-103-5p (for the normalization of the results). Receiver operating characteristics (ROC) curves and the area under the curve (AUC) were used to evaluate the feasibility of using selected markers as biomarkers for detecting BC and discriminating non-muscle invasive BC (NMIBC) from muscle invasive BC (MIBC). For HG tumors, the relevant classifiers are miR-205-5p and miR-20a-5p, whereas miR-205-5p and miR-182-5p are for LG (AUC = 0.964 and AUC = 0.992, respectively). NMIBC patients with LG disease are characterized by significantly higher miR-130b-3p expression values compared to patients in HG tumors.
format Online
Article
Text
id pubmed-6826751
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-68267512019-11-18 MicroRNAs Which Can Prognosticate Aggressiveness of Bladder Cancer Borkowska, Edyta Marta Konecki, Tomasz Pietrusiński, Michał Borowiec, Maciej Jabłonowski, Zbigniew Cancers (Basel) Article Bladder cancer (BC) is still characterized by a very high death rate in patients with this disease. One of the reasons for this is the lack of adequate markers which could help determine the biological potential of the tumor to develop into its invasive stage. It has been found that some microRNAs (miRNAs) correlate with disease progression. The purpose of this study was to identify which miRNAs can accurately predict the presence of BC and can differentiate low grade (LG) tumors from high grade (HG) tumors. The study included 55 patients with diagnosed bladder cancer and 30 persons belonging to the control group. The expression of seven selected miRNAs was estimated with the real-time PCR technique according to miR-103-5p (for the normalization of the results). Receiver operating characteristics (ROC) curves and the area under the curve (AUC) were used to evaluate the feasibility of using selected markers as biomarkers for detecting BC and discriminating non-muscle invasive BC (NMIBC) from muscle invasive BC (MIBC). For HG tumors, the relevant classifiers are miR-205-5p and miR-20a-5p, whereas miR-205-5p and miR-182-5p are for LG (AUC = 0.964 and AUC = 0.992, respectively). NMIBC patients with LG disease are characterized by significantly higher miR-130b-3p expression values compared to patients in HG tumors. MDPI 2019-10-14 /pmc/articles/PMC6826751/ /pubmed/31615011 http://dx.doi.org/10.3390/cancers11101551 Text en © 2019 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Borkowska, Edyta Marta
Konecki, Tomasz
Pietrusiński, Michał
Borowiec, Maciej
Jabłonowski, Zbigniew
MicroRNAs Which Can Prognosticate Aggressiveness of Bladder Cancer
title MicroRNAs Which Can Prognosticate Aggressiveness of Bladder Cancer
title_full MicroRNAs Which Can Prognosticate Aggressiveness of Bladder Cancer
title_fullStr MicroRNAs Which Can Prognosticate Aggressiveness of Bladder Cancer
title_full_unstemmed MicroRNAs Which Can Prognosticate Aggressiveness of Bladder Cancer
title_short MicroRNAs Which Can Prognosticate Aggressiveness of Bladder Cancer
title_sort micrornas which can prognosticate aggressiveness of bladder cancer
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6826751/
https://www.ncbi.nlm.nih.gov/pubmed/31615011
http://dx.doi.org/10.3390/cancers11101551
work_keys_str_mv AT borkowskaedytamarta micrornaswhichcanprognosticateaggressivenessofbladdercancer
AT koneckitomasz micrornaswhichcanprognosticateaggressivenessofbladdercancer
AT pietrusinskimichał micrornaswhichcanprognosticateaggressivenessofbladdercancer
AT borowiecmaciej micrornaswhichcanprognosticateaggressivenessofbladdercancer
AT jabłonowskizbigniew micrornaswhichcanprognosticateaggressivenessofbladdercancer